The Clorox Company (CLX)
Consumer Defensive · Household & Personal Products · Data as of 2026-09-01
Bottom line
CLX is trading near its usual valuation, in the middle of its recent price range, and recent volume shows no clear direction. The picture is mixed, so it may be worth watching rather than acting on. Past patterns are not a guarantee of future results.
Valuation — Cheap-looking, with quality flags (Yellow)
CLX trades at 21× earnings, below its own 5-year average of 35× and roughly in line with similar consumer defensive companies we track (23×, 30 peers). Historically this has been on the cheaper side for the stock. Its free-cash-flow yield is about 3.3%. One caution: revenue has been shrinking, so the low multiple may reflect a weakening business rather than a bargain. Its current multiple sits around the 26th percentile of its own last five years — toward the low end of its own range. About 69% of its reported earnings arrived as free cash over the last year.
Quality check: the dividend consumes about 103% of earnings. An apparent discount can reflect balance-sheet strain rather than a bargain.
Price zones — In the middle of its recent range (Yellow)
At $94.97, the stock sits between its recent support and resistance levels. Over the past year CLX has traded between $84.70 and $128.90; its historical support zone sits near $84.70 and resistance near $99.89. It is below both its 50- and 200-day averages, which has historically signalled a downtrend.
52-week range $84.70–$128.90 · 50-day average $99.89 · 200-day average $103.31
Money flow — No clear direction (Yellow)
Buying and selling volume in CLX have been fairly balanced recently, with no strong accumulation or distribution pattern. Volume on up days has been about 0.9× volume on down days over the last 30 sessions.
About the company
The Clorox Company is a global manufacturer and marketer of both consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division offers a range of cleaning solutions, including laundry additives and home care items under brand names such as Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409. It also supplies professional cleaning and disinfecting products via the CloroxPro and Clorox Healthcare brands, alongside professional food service goods from Hidden Valley.
一句话结论
CLX 估值接近其惯常水平，处于近期价格区间的中部，近期成交量没有明确方向。整体情况好坏参半，也许更适合先观察，而不是急于行动。过去的形态并不能保证未来的结果。
估值 — 看似便宜，但有质量警示
CLX 目前的市盈率为 21×，低于其自身 5 年平均的 35×，并且大致持平于我们追踪的同类Consumer Defensive公司（23×，30 家）。从历史来看，这属于该股较便宜的一侧。其自由现金流收益率约为 3.3%。有一点需要留意：营收一直在萎缩，因此较低的估值倍数可能反映的是业务转弱，而非便宜。它当前的估值倍数大约位于自身过去五年分布的第 26 百分位——处于自身区间的偏低位置。过去一年，其报告利润中约有 69% 转化为自由现金。
质量核对：股息大约消耗了 103% 的利润。表面的折价有时反映的是资产负债表的压力，而不是便宜。
价格区间 — 处于近期区间的中部
目前价格为 $94.97，位于其近期的支撑位与阻力位之间。过去一年 CLX 的价格在 $84.70 到 $128.90 之间波动；其历史支撑区在 $84.70 附近，阻力区在 $99.89 附近。它同时位于 50 日和 200 日均线下方，这在历史上通常对应下降趋势。
资金流向 — 方向不明确
CLX 近期的买卖成交量大致均衡，没有明显的吸筹或派发形态。过去 30 个交易日，上涨日的成交量约为下跌日的 0.9×。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.